Muthukumarasamy Raja/LinkedIn
Aug 13, 2026, 18:31
Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
Muthukumarasamy Raja, Managing Director at GeniusArena Software B.V., shared a post on LinkedIn:
“Plasma is essential in severe bleeding because it replaces lost blood volume and provides clotting factors that help stop hemorrhage.
Yet, traditional plasma was difficult to use in emergencies because it required freezing, lengthy thawing, and strict cold-chain storage.
The FDA’s 2026 approval of EZPLAZ freeze-dried plasma represents a real breakthrough in emergency care by making plasma rapidly available where and when it is needed most.
Join JobsReach Healthcare, the healthcare industry network, to join the conversation, share your knowledge, and discover healthcare insights and opportunities.”
Stay updated with Hemostasis Today.
-
Nov 16, 2026, 15:35Jim Hoffman: Could Blood Purification Change the Fight Against Cancer?
-
Nov 16, 2026, 15:16How Do Artificial Hearts Affect Platelet Function? – Platelets Journal
-
Nov 16, 2026, 15:10Assessing Coagulation Activation in DOAC – Treated Patients – JTH
-
Nov 16, 2026, 15:00Davide Antonio Mei: Should Anticoagulation Continue After AF Ablation?
-
Nov 16, 2026, 14:55Danielle Boyle: Beyond Platelet Counts – Why Patient Stories Matter
-
Nov 16, 2026, 14:28Jan Sloves: The Future of Vascular Ultrasound
-
Nov 16, 2026, 13:49Bahman Rasouli: A Rare Vascular Manifestation of Recurrent Papillary Thyroid Carcinoma
-
Nov 16, 2026, 13:28Muhammad Danyal: Platelet Patterns in Hepatitis B and C
-
Nov 16, 2026, 12:52Frank Nocken: Alzheimer’s Research Expands Beyond Amyloid-Based Treatments